Evaluation of the PACE/PACENET BHL Clinical Program
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 65 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 6 months
- Procedures mentioned: Interviews
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "These brief interviews monitor symptoms, adherence, side effects, and response to treatment."
- "Clinical Program Procedures: Referred PACE/PACENET enrollees are contacted to complete an initial baseline clinical interview."
- "Following the baseline interview, enrollees are offered several different services, depending on clinical need: Referral Management, Care Management, or Monitoring."
- "Enrollee participation in the program occurs over the span of up to six months, with the number of calls based upon the follow-up service."
- "Enrollees providing verbal consent to participate in the 6 Month Outcome Research Evaluations will be called again at 6 months following the date of the initial clinical interview."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
The SUpporting Seniors Receiving Treatment And INtervention (SUSTAIN) program is a telephone-based clinical service designed to help identify and manage behavioral health issues among PACE/PACENET enrollees. The purpose of the current project is to a) explore moderators of treatment response among beneficiaries in the SUSTAIN Clinical Program and b) to evaluate the sustained clinical effects of the program.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: 1. Aged 65 and older, males and females. 2. Participating in the SUSTAIN Clinical Program 3. For the 6 Month Outcome Research Evaluation, in addition to meeting criteria 1 and 2, willing to provide verbal informed consent to participate in the 6 Month Outcome Research Evaluation at the end of the acute phase of clinical care, usually at three months. Exclusion Criteria: * Not meeting the inclusion criteria listed above.
Study sites (1)
PA
- Department of Psychiatry (Center for Psychotherapy Research), University of Pennsylvania · Philadelphia, PA 19104Mary Beth Gibbons, PhD · Study contact · (215)662-3488 · gibbonsm@pennmedicine.upenn.eduDavid W Oslin, MD · Sub-investigatorMary Beth Gibbons, PhD · Principal investigatorMore trials in Philadelphia